The Immune System – News and Features

Clinical trials to be conducted in Beijing, China with renowned hematologist.

Alnylam and Stanford University’s findings published in the journal Cell show that miR-181a regulates T cell responses to antigens.

The researchers are able to track the delivery, survival and function of donor stem cells using microcapsules that are visible using X-ray imaging techniques.

Procognia will combine its protein array technology with GSK’s fluorescently-labelled kinase inhibitors to enable GSK to profile its kinase hits in-house.

Calando has published results of the non-human primate study to use multiple, systemic dosing with its lead siRNA therapeutic candidate.

University of Michigan Health System researchers says that there findings could help with transplant rejection.

VentiRx acquires exclusive worldwide rights to toll-like receptor program from Array to develop candidates in oncology and allergy.

The Company’s immunogenicity screening tool for protein therapeutics has been granted a European patent.

Senior scientist Dr Mike Gresser, with experience at Amgen and Merck will assist the drive to develop new personalised medicines.

Lorry I. Lokey, the founder of Business Wire will give $33 million to help build new laboratories for Stanford’s Institute for Stem Cell Biology and Regenerative Medicine.